Floatz logo

Therapeutic Asset Ratings

4,361 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Advanced Solid Tumor
National Cancer Institute (NCI)P3B (62)
Docetaxel
Head And Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)P3B (62)
Entinostat
Breast Carcinoma
National Cancer Institute (NCI)P3B (62)
Epoetin Alfa
Acute Myeloid Leukemia
National Cancer Institute (NCI)P3B (62)
Fludarabine
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P3B (62)
Nivolumab
Bone Metastases
National Cancer Institute (NCI)P3B (62)
TAMOXIFEN
Breast Adenocarcinoma
National Cancer Institute (NCI)P3B (62)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
Melanoma
National Cancer Institute (NCI)P2B (62)
Atezolizumab
Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2B (62)
Azacitidine
Acute Megakaryoblastic Leukemia In Adult
National Cancer Institute (NCI)P2B (62)
Azacitidine
Adult Pure Erythroid Leukemia
National Cancer Institute (NCI)P2B (62)
AZD1775
Refractory Malignant Neoplasm
National Cancer Institute (NCI)P2B (62)
Bet Bromodomain Inhibitor Zen-3694
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (62)
Bortezomib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2B (62)
cd22 car-transduced t cells
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P2B (62)
Cediranib
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (62)
Cyclophosphamide
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)P2B (62)
Durvalumab
Recurrent Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2B (62)
Eloxatin
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI)P2B (62)
Fludarabine
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)P2B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Breast Cancer
National Cancer Institute (NCI)P2B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2B (62)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (62)
Ipilimumab
Ovarian Carcinoma
National Cancer Institute (NCI)P2B (62)
Irinotecan
Adenosquamous Cell Lung Cancer
National Cancer Institute (NCI)P2B (62)
Showing 551 to 575 of 4,361 assets
PreviousPage 23 of 175Next